Aimovig 140 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26F1AB2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,942
Award facts
- Contract value 100% obligated
- $16,942.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,942.28 to AmerisourceBergen Drug Corp for the supply of Aimovig 140 mg/mL auto-injectors. The contract, executed on January 15, 2026, with completion by January 16, 2026, utilizes firm fixed-price pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc. and operates as a critical pharmaceutical distributor supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare systems worldwide.
Aimovig is a monoclonal antibody medication used for migraine prevention, representing the type of specialized pharmaceutical product that falls within the scope of AmerisourceBergen's extensive IDC portfolio covering specialty medications, brand-name drugs, and medical devices across multiple therapeutic domains. The non-set-aside, competitively awarded nature of this delivery order reflects AmerisourceBergen's demonstrated capability to meet federal procurement requirements in open competition. The company's role as a pharmaceutical prime vendor to the Defense Logistics Agency underscores its significance in supporting Defense Health Agency operations and broader military healthcare supply chain requirements.
Quick answers
Who was awarded contract SPE2DR26F1AB2?
SPE2DR26F1AB2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F1AB2 worth?
The government has obligated $16,942 on SPE2DR26F1AB2.
Is contract SPE2DR26F1AB2 an order under another contract?
Yes. SPE2DR26F1AB2 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AB2 competed?
The extent of competition for SPE2DR26F1AB2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award